Tackling cardiovascular diseases with a new generation of polypills
CHANNEL
Topic:
Epidemiology
Session type:
Industry Q&A session
Date:
Time:*
-
See more details
Chairperson
Charalambos Vlachopoulos (Athens, Greece)Subtitle
Sponsored by SERVIERLearning objectives
Dyslipidemia and hypertension are the most important risks factors of cardiovascular diseases The more frequent use of a new generation of polypills is the best way to optimize adherence to treatment and thus prognosis in cardiovascular patientsPresentations
Benefits of controlling both blood pressure and LDL-cholesterol in terms of cardiovascular protection.
Speaker: Bryan Williams (London, United Kingdom of Great Britain & Northern Ireland)
Time:
Speaker: Bryan Williams (London, United Kingdom of Great Britain & Northern Ireland)
Time:
From pathophysiology to clinical benefits: what new combinations of a statin and antihypertensive drugs can provide.
Speaker: Claudio Borghi (Bologna, Italy)
Time:
Speaker: Claudio Borghi (Bologna, Italy)
Time: